{"id":44586,"name":"GLOBAL ALZHEIMER'S PLATFORM INNOVATIONS PBC","slug":"global-alzheimers-platform-innovations-pbc","state":"DC","country":"United States of America","description":"Drive innovation in Alzheimer's Disease therapies and the clinical trial process.","totalSpending":192000,"filings":9,"yearlySpending":[{"year":2022,"income":96000},{"year":2023,"income":96000}],"issues":[{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["TWENTY-FIRST CENTURY GROUP, INC."],"lobbyists":["JACK FIELDS","LINDSAY FLYNN","LISA RULLI"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to improving the clinical trial process for Alzheimers therapies and expediting the search for a cure.","Issues related to improving the clinical trial process for Alzheimers therapies and expediting the search for a cure.","Issues related to improving the clinical trial process for Alzheimers therapies and expediting the search for a cure.","Issues related to diversity in clinical trials, Alzheimers research, and ARPA-H.","Issues related to Medicare coverage of Alzheimers treatments."]}